Article metrics

Download PDFPDF

697 A phase 1 study of AMG 119, a DLL3-targeting, chimeric antigen receptor (CAR) T cell therapy, in relapsed/refractory small cell lung cancer (SCLC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to May 2024

AbstractFullPdf
Nov 2022208011
Dec 2022106012
Jan 2023234032
Feb 2023294025
Mar 2023248029
Apr 2023238034
May 2023250020
Jun 2023244026
Jul 2023260039
Aug 2023388054
Sep 2023348035
Oct 2023306035
Nov 2023476058
Dec 2023336036
Jan 2024132021
Feb 2024184018
Mar 2024366030
Apr 2024386041
May 2024348024
Total53520580